6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride
C41H54Cl4F2N8 — CID 173002434
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride
6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride (PubChem CID 173002434) has the molecular formula C41H54Cl4F2N8 and a molecular weight of 838.75 g/mol. Its IUPAC name is 6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride.
Molecular Properties
| Compound Name | 6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride |
|---|---|
| PubChem CID | 173002434 |
| Molecular Formula | C41H54Cl4F2N8 |
| Molecular Weight | 838.75 g/mol |
| Exact Mass | 836.32 |
| IUPAC Name | 6-[(2R,5R)-1-[4-(4-tert-butylpiperidin-1-yl)-3,5-difluorophenyl]-5-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole;tetrahydrochloride |
| SMILES | CC(C)(C)C1CCN(c2c(F)cc(N3[C@@H](c4ccc5nc([C@@H]6CCCN6)[nH]c5c4)CC[C@@H]3c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)cc2F)CC1.Cl.Cl.Cl.Cl |
| InChI | InChI=1S/C41H50F2N8.4ClH/c1-41(2,3)26-14-18-50(19-15-26)38-28(42)22-27(23-29(38)43)51-36(24-8-10-30-34(20-24)48-39(46-30)32-6-4-16-44-32)12-13-37(51)25-9-11-31-35(21-25)49-40(47-31)33-7-5-17-45-33;;;;/h8-11,20-23,26,32-33,36-37,44-45H,4-7,12-19H2,1-3H3,(H,46,48)(H,47,49);4*1H/t32-,33-,36+,37+;;;;/m0..../s1 |
| InChIKey | ZOZIFMGILYBYBL-FKWXLENZSA-N |
| XLogP | 10.60 |
| TPSA | 87.90 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 838.75 |
| LogP ≤ 5 | 10.60 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 173002434 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.